Skip to content
    M

    MIG

    Munich, GermanyFounded 2004
    Biotech & Life SciencesDeveloper ToolsLogistics & Supply ChainInfrastructure & Cloud

    MIG Capital is a venture capital firm that primarily focuses its investments on early-stage deep tech and life sciences companies in German-speaking Europe and beyond. Their strategy involves supporting innovative solutions and transforming visions into successful businesses.

    50% of their portfolio is in Biotech & Life Sciences. Deal activity increased 100% year-over-year (2 deals in the last 12 months). Average disclosed round size is $33.5M (across 6 rounds with reported amounts).

    Find people at MIG on Goldilocks AI

    Portfolio

    6

    Fund Size

    $1.3B

    Top Stage

    Series A

    Last 12 Mo

    2

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    6 investments
    CompanyRoundAmountDate
    NNcodiNSeed$16MNov 2025
    ASTRA Therapeutics logoASTRA TherapeuticsSeed$7.8MJul 2025
    SciRhom GmbH logoSciRhom GmbHSeries A$70MJul 2024
    AAMSilkSeries C$25MApr 2023
    GoBolt logoGoBoltSeries C$75MDec 2022
    KONUX logoKONUXSeries A$7.5MApr 2016

    Top Co-Investors

    NEA (New Enterprise Associates)1 shared
    Yaletown Partners1 shared
    Export Development Canada1 shared
    BDC Capital1 shared
    Northleaf Capital Partners1 shared
    Whitecap Venture Partners1 shared
    BMO Capital Partners1 shared
    PhotonVentures1 shared
    Earlybird Venture Capital1 shared
    ATHOS1 shared
    Novo Holdings1 shared
    Cargill1 shared
    Digitalis Ventures1 shared
    Kickfund1 shared
    Andera Partners1 shared
    Kurma Partners1 shared
    Hadean Ventures1 shared
    Wellington Management1 shared
    Bayern Kapital1 shared
    HTGF1 shared

    Last updated: 18 March 2026